Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mequitazine for perennial allergic rhinitis
2007-003905-28Phase 4Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Mequitazine in perennial rhinitis (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Change in nasal symptom score. Started Sep 2007; status: completed.
02
Drugs
Mequitazine
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on 2007-003905-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003905-28.